SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare
8 references·0 citing·42 second hop
Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare (2023)Cost-Benefit Analysis versus Cost-Effecti…Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions (2019)Family and Caregiver Spillove…Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Recommendations for Conduct, …Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)Updating Cost-Effectiveness —…Adjusting the Value of a Statistical Life for Age and Cohort Effects (2008)Adjusting the Value of a Stat…Valuing Health Care (1995)Valuing Health CareThe relationship between cost-effectiveness analysis and cost-benefit analysis (1995)The relationship between cost…Some guidelines on the use of cost effectiveness league tables. (1993)Some guidelines on the use of…General Equilibrium Computations of the Marginal Welfare Costs of Taxes in the United States.General Equilibrium Computati…Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Economics of coronary artery bypass grafting. (1985)The value of risks to life and health (1993)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Evaluation and Decision Models (2000)Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis? (2002)Willingness to Pay for a Quality-adjusted Life Year (2000)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Economics and mental health: the current scenario (2020)Measurement of health state utilities for economic appraisal (1986)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)A study of the quality of life and cost-utility of renal transplantation (1996)When should decision-analytic modeling be used in the economic evaluation of health care? (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another (2007)The Pure Theory of Public Expenditure (1954)The Incidence of the Corporation Income Tax (1962)Medical Care Costs: How Much Welfare Loss? (1992)What Really Matters in Auction Design (2002)Monitoring Corruption: Evidence from a Field Experiment in Indonesia (2007)Optimal Taxation and Public Production I: Production Eficiency (2016)Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Understanding Costs of Care in the Operating Room (2018)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals (2020)Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force (2023)Chapter 22 Panel data (1984)Panel data from time series of cross-sections (1985)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2003)Age Differences in the Value of Statistical Life: Revealed Preference Evidence (2007)The Value of a Statistical Life: Evidence from Panel Data (2011)Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds (2016)Alternative approaches to valuing intangible health losses: the evidence for multiple sclerosis (1998)Cost-Effectiveness Analyses of Vaccination Programmes (2008)Cost Effectiveness in Low- and Middle-Income Countries (2009)
this work references cited by second hop

References

  • 2016Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses3,139 cited
  • 2014Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold2,303 cited
  • n.d.General Equilibrium Computations of the Marginal Welfare Costs of Taxes in the United States.650 cited
  • 2008Adjusting the Value of a Statistical Life for Age and Cohort Effects363 cited
  • 1993Some guidelines on the use of cost effectiveness league tables.219 cited
  • 1995Valuing Health Care211 cited
  • 1995The relationship between cost-effectiveness analysis and cost-benefit analysis102 cited
  • 2019Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions69 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work